(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
PARP Inhibitors for Cancer Therapy provides a comprehensive overview of the role of PARP in cancer therapy. The volume covers the history of the discovery of PARP (poly ADP ribose polymerase) and its role in DNA repair. In addition, a description of discovery of the PARP family, and other DNA maintenance-associated PARPs will also be discussed. The volume also features a section on accessible chemistry behind the development of inhibitors.
PARP inhibitors are a group of pharmacological inhibitors that are a particularly good target for cancer therapy. PARP plays a pivotal role in DNA repair and may contribute to the therapeutic resistance to DNA damaging agents used to treat cancer. Researchers have learned a tremendous amount about the biology of PARP and how tumour-specific defects in DNA repair can be exploited by PARPi. The "synthetic lethality" of PARPi is an exciting concept for cancer therapy and has led to a heightened activity in this area.
Contents:
Section 1: What PARP is and What it Does
1. History of the discovery of poly (ADP-ribose)
Takashi Sugimura and Sydney Shall
2. Discovery of the PARP superfamily and focus on the lesser exhibited but not lesser talented members
Elea Heberle, Jean-Christophe Ame, Giuditta Illuzzi, Francoise Dantzer, Valerie Schreiber
3. The role of PARPs in DNA Strand Break Repair
Stuart L. Rulten, Francoise Dantzer and Keith W. Caldecott
4. TIPs: Tankyrase Interacting Proteins
Susan Smith
5. PARP and Carcinogenesis
Junhui Wang, Akira Sato, Hiroaki Fujimori, Yoshio Miki, Mitsuko Masutani
6. Multitasking roles for poly(ADP-ribosyl)ation in aging and longevity
Aswin Mangerich and Alexander BurkleSection 2. NAD catalysis and the identification of inhibitors
7. Overview of PARP Inhibitor Design and Optimization
Dana Ferraris
8. Structure Based Design of PARP Inhibitors
Stacie S. Canan
Section 3. Chemo- and radiosensitisation in vitro and in vivo
9. Preclinical chemosensitization by PARP inhibitors
David R. Shalinsky, Cherrie K. Donawho. Gerrit Los, and Joanne P. Palma
10. Classification of PARP inhibitors based on PARP trapping and catalytic inhibition, and rationale for combinations with topoisomerase I inhibitors and alkylating agents
Junko Murai and Yves Pommier
11. Radiosensitisation by poly(ADP-ribose) polymerase inhibition
Charles Fouillade, Alexis Fouquin, Mohammed-Tayyib Boudra, Vincent Favaudon, Vincent Pennaneach, Janet Hall
12. The vasoactivity of PARP inhibitors
Cian M. McCrudden and Kaye J. Williams
Section 4. Synthetic lethality
13. Synthetic lethality with Homologous Recombination Repair defects
Helen E. Bryant, Sydney Shall
14. Targeting tumour hypoxia with PARP Inhibitors: Contextual synthetic lethality
Katarzyna B. Leszczynska, Nadya Temper, Robert G. Bristow and Ester M. Hammond
15. Other determinants of sensitivity
Naoyuki Okita and Atsushi Shibata
16. Synthetic sickness with molecularly targeted agents against the EGFR pathway
Jennifer A. Stanley and Eddy S Yang
17. Disruption of DNA repair by cell cycle and transcriptional CDK inhibition
Liam Cornell, Neil Johnson and Geoffrey I. Shapiro
18. Resistance to PARP Inhibitors Mediated by Secondary BRCA1/2 Mutations
Kiranjit K. Dhillon and Toshiyasu Taniguchi
19. PARP inhibitor resistance - what is beyond BRCA1 or BRCA2 restoration
Guotai Xu, Jos Jonkers, Sven Rottenberg
Section 5. Clinical status
20. Introduction to PARPi clinical trials and future directions
Ruth Plummer and Yvette Drew
21. Clinical trials investigating PARP inhibitors as single agents
Sheeba Irshad and Andrew Tutt
22. Clinical trials of PARP inhibitors with chemotherapy
Ashley K. Clift, Nicholas Coupe and Mark R. Middleton
23. Combination of PARP inhibitors with clinical radiotherapy
Ross Carruthers, Anthony J. Chalmers
24. Biomarkers for PARP Inhibitors
C. Dearman, Ricky A. Sharma, Nicola Curtin
PRODUCT DETAILS
Publisher: Springer (Birkhauser Verlag AG)
Publication date: June, 2015
Pages: 562
Weight: 652g
Availability: Available
Subcategories: General Issues, Oncology, Pharmacology
From the same series
Jorge J. Castillo
Moulay A. Alaoui-Jamali
Gail Lewis Phillips
Frank E. Koehn
Beverly A. Teicher
Gary J. Kelloff
Ryan J. Sullivan
Gary K Schwartz
Val R Adams
Antonio Tito Fojo
William D. Figg
Steven Kanner
Giovanni Melillo
Masaki Terabe
Yves Pommier
Derek LeRoith
Beverly A. Teicher
Ann L. Jackman
Jorge J. Castillo
Manuel Hidalgo
Vinata B. Lokeshwar
Beverly A. Teicher
Moulay A. Alaoui-Jamali
Saïd M. Sebti
Frank E. Koehn
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
Beverly A. Teicher
Alan M. Gewirtz
Michael A Morse
Janusz W. Rak
J. Silvio Gutkind
Maryann Foote
Zahid H. Siddik
L. Harivardhan Reddy
Gavin J. Gordon
Masaki Terabe
Yves Pommier
Derek LeRoith
Neil J. Clendeninn
Howard L. Kaufman
John D. Haley
Manuel Hidalgo
Beverly A. Teicher
Ulrike Stein
Pat Price
Kelly K. Hunt
Mary L. Disis
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Nicholas P. Farrell
Vinata B. Lokeshwar
Beverly A. Teicher
Giampietro Gasparini
Doriano Fabbro
Nicholas B. La Thangue
David E. Fisher
Beverly A. Teicher
John A. Hickman
Godefridus J. Peters
Julian Adams
Sonia Jakowlew
Antonio Giordano
Youcef M. Rustum
Michel Page
Gurmit Singh
Gary J. Kelloff
Moulay A. Alaoui-Jamali
Wafik S. El-Deiry
Keiko Hiyama
Amy M. Fulton
Federico Innocenti
Hak Choy
Sonia Jakowlew
Dennis M. Brown
Michael T. Lotze
Randall E. Harris
Eric Verdin
Benjamin Bonavida
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
L. Harivardhan Reddy
V. Craig Jordan
Zahid H. Siddik
Erwin G. van Meir
Amy M. Fulton
Beverly A. Teicher
Keiko Hiyama
Gavin J. Gordon
David S. Ettinger
Federico Innocenti
John D. Haley
Benjamin Bonavida
Antonio Tito Fojo
Sonia Jakowlew
Sonia Jakowlew
Howard L. Kaufman
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Pat Price
Michael T. Lotze
Ulrike Stein
Kelly K. Hunt
Godefridus J. Peters
Beverly A. Teicher
Eric Verdin